Accelerated Glomerular Cell Senescence in Experimental Lupus Nephritis

Area of Science:

• Nephrology
• Immunology
• Cellular Biology

Background:

• Lupus nephritis (LN) is an autoimmune disease causing kidney inflammation and damage.
• Cellular senescence, a state of irreversible growth arrest, is increasingly recognized in chronic kidney diseases.
• The role of glomerular senescence in the pathogenesis of lupus nephritis remains unclear.

Purpose of the Study:

• To investigate the presence and significance of glomerular senescence in a mouse model of lupus nephritis.
• To examine the association between senescence markers and glomerular injury in lupus nephritis.
• To evaluate the effect of dexamethasone treatment on glomerular senescence and kidney lesions.

Main Methods:

• MRL/lpr mice with lupus nephritis were treated with dexamethasone (DEX) or saline.
• Kidney tissues were analyzed for senescence-associated β-galactosidase (SA-β-Gal) expression.
• Histological changes, collagen IV, α-SMA, nephrin, and C3 deposition were assessed.
• Correlation analysis was performed between SA-β-Gal and renal function/lesion markers.

Main Results:

• Proteinuric MRL/lpr mice showed glomerular sclerosis and endothelial proliferation.
• DEX treatment reduced glomerular SA-β-Gal expression, C3 deposition, and collagen IV/α-SMA levels.
• DEX treatment increased nephrin expression but did not significantly alter 24-hour urinary protein.
• SA-β-Gal expression positively correlated with urinary protein and α-SMA levels.

Conclusions:

• Accelerated senescence of glomerular cells contributes to kidney injury in lupus nephritis.
• Targeting cellular senescence may represent a therapeutic strategy for lupus nephritis.
• SA-β-Gal serves as a potential biomarker for glomerular damage in lupus nephritis.